HLB Therapeutics Co Ltd
KOSDAQ:115450
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
HLB Therapeutics Co Ltd
Accounts Receivables
HLB Therapeutics Co Ltd
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
HLB Therapeutics Co Ltd
KOSDAQ:115450
|
Accounts Receivables
₩14.3B
|
CAGR 3-Years
21%
|
CAGR 5-Years
26%
|
CAGR 10-Years
20%
|
|
|
Celltrion Inc
KRX:068270
|
Accounts Receivables
₩2T
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
12%
|
|
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
Accounts Receivables
₩1.1B
|
CAGR 3-Years
10%
|
CAGR 5-Years
91%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Accounts Receivables
₩80.8m
|
CAGR 3-Years
332%
|
CAGR 5-Years
141%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Accounts Receivables
₩37.2B
|
CAGR 3-Years
64%
|
CAGR 5-Years
81%
|
CAGR 10-Years
57%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Accounts Receivables
₩59.1B
|
CAGR 3-Years
2 371%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
HLB Therapeutics Co Ltd
Glance View
HLB Therapeutics Co., Ltd. engages in the development and sale of vaccines and manufacture of electronic parts. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2010-03-26. Along with its affiliates, the Company operates solution business segment, which provides embedded graphic user interface (GUI) software solutions as well as wired and wireless integration multimedia platform solutions. Its embedded GUI products include FXUI-two-dimensional (2D), FXUI-three-dimensional (3D) and FX Studio, which are used for cellular phones and embedded equipment. Its wired and wireless integration multimedia platform products include FX-Flash and others, which are used for cellular phones and other mobile devices; electronic components manufacturing business segment, which provides transformers, pumps, motors and others, as well as educational and bio pharmaceutical business segments.
See Also
What is HLB Therapeutics Co Ltd's Accounts Receivables?
Accounts Receivables
14.3B
KRW
Based on the financial report for Dec 31, 2025, HLB Therapeutics Co Ltd's Accounts Receivables amounts to 14.3B KRW.
What is HLB Therapeutics Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
20%
Over the last year, the Accounts Receivables growth was 65%. The average annual Accounts Receivables growth rates for HLB Therapeutics Co Ltd have been 21% over the past three years , 26% over the past five years , and 20% over the past ten years .
